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Chagas'  disease occurs in Central  and South America in individuals infected with 
the protozoan Trypanosoma cruzL In the acute stage of the disease, subcutaneous 
swelling around the eye (chagoma), myocardit is,  encephalit is, and fever are observed. 
These condit ions are related to the invasion of the tissues by the parasite (1). Years 
later, in the chronic stage of Chaga s' disease, when few, if any, parasites are present 
in the tissues, inf lammatory,  degenerative, and fibrotic changes are observed, partic- 
ularly in the endocardium, myocardium, esophagus, and colon (1, 2). Such lesions 
can be life threatening (1). 
Immunological  causes are thought to underl ie the chronic lesions in Chagas'  disase 
(3). Sera from both acute and chronic cases of Chagas'  disease show reactivity with 
the parasite as well as with normal  endocardium, blood vessels, and the interst it ium 
of str iated muscle (the so-called EVI  1 pattern),  and Schwann sheaths of per ipheral  
nerve (4-6). Studies on skeletal muscle biopsies of individuals infected with T. cruzi 
indicate the existence of immunoglobul ins (Ig) with a similar distr ibution (4). The 
extent of the clinical alterations found in individuals with chronic Chagas'  disease 
was correlated with these tissue-reacting antibodies in one (4) but not in other 
geographical  areas (7). These antibodies were not found to occur in various other 
heart diseases examined (4). Here, we demonstrate that these antibodies react with 
connective tissue structures. We also have assayed purif ied components of connective 
tissues for their reaction with the antibodies present in humans and in Rhesus 
monkeys infected with T. cruzi. Our  studies indicate that these antibodies are specific 
for laminin (8), a basement membrane glycoprotein, which mediates the attachment  
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of epithel ial  and  endothel ia l  cells to type IV col lagen (9). 
Mater ia l s  and  Methods  
Patients. Sera were examined from nine patients, ages 18-40, with chronic Chagas' disease 
(five with cardiomegaly and three with megacolon) in whom the infection had been present for 
at least 5 yr (mean 7 yr). In addition, sera were studied from six patients between the ages of 
3 mo and 4 yr in whom acute Chagas' disease was present. Each child had unilateral chagoma 
of the eye and acute myocarditis within the last 2 mo, and the diagnosis was confirmed by 
identifying parasites in blood smears. All patients had a positive serology (titers _>1:64) for T. 
cruzi by the indirect immunofluorescence (IF) test using cultured epimastigote forms of the 
parasite (Tulahuen strain) (10). Sera of 20 normal individuals and 10 patients with inflam- 
matory diseases other than Chagas' disease (3 with osteomyelitis, 4 with paracoccidioidomycosis, 
and 4 with bacterial meningitis) from the same geographical reas (Argentina nd Brazil), all 
showed a negative reaction for T. cruzi (10). Additional negative controls included sera from 10 
patients with surgical wounds and 10 with invasive neoplasms of the breast and digestive 
system, 10 with toxoplasmosis, 10 with rheumatoid arthritis, and 10 with malaria, all from the 
United States. 
Infected Monkeys. The insect Dzpetalogaster maximus, infected 3 mo earlier with blood from an 
acute case of Chagas' disease, was kindly supplied by Dr. P. Marsden from the University of 
Brasilia, Brasilia, Brazil. Two Rhesus monkeys were infected under the eyelid with 1,000 
metacyclic trypomastigotes obtained from the feces of the insect. After infection of the monkey, 
T. cruzi trypomastigotes were observed in blood smears, and 1 mo after infection the animals 
were found to have developed antibodies against he parasite (titer ___ 1:64) (10). 
Parasites. Human foreskin fibroblasts train CRL 1475 (kindly provided by Dr. W. Gleiber, 
National Institutes of Health), which do not synthesize laminin, were grown in Dulbecco's 
modified Eagle's medium (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY) 
with 4% fetal calf serum (Gibco Laboratories). When confluent, cells were infected with blood 
trypomastigote forms of T. cruzi, Tulahuen strain (kindly provided by Dr. T. Mercado, National 
Institutes of Health). The amastigote and trypomastigote stages were obtained from the 
supernatant fluids from cultures 5 d after infection. Epimastigotes were cultured in ox liver- 
infusion tryptose (LIT) medium pH 7.2 as described (11). Blood trypomastigotes were purified 
as described (12). The parasites were fixed with 0.5% paraformaldehyde, allowed to dry on 
slides, and used as antigens in an indirect IF test (10). The purified antibodies were used at a 
concentration of 50 /tg/ml. The unbound fraction was reconstituted to the original serum 
volume and used diluted 1:10. 
Laminin. Laminin was extracted from the Engelbreth-Holm-Swarm (EHS) tumor grown in 
C57 BI mice and was isolated as previously described (8). For additional purification, 10 mg of 
laminin, dissolved in 1 ml of 8 M urea, 0.05 M Tris-HCl, pH 8.6, was applied to a column of 
DEAE-cellulose (2.5 X 25 era) and eluted with a gradient of 0-0.3 M NaCI. Portions of the 
collected fractions were subjected to sodium dodecyl sulfate polyacrylamide g l electrophoresis 
or tested as antigen in an enzyme-linked immunoabsorbent assay (ELISA) (sera were diluted 
1:50, and purified antibodies were used at 50/~g/ml) (see below). Various fragments of mouse 
laminin (PI from soluble laminin and Pli, Pb, and Pc from insoluble laminin), obtained from 
laminin by digestion with pepsin (Boehringer, Federal Republic of Germany) (20 mg/g 
laminin), were a gift from Dr. Rupert Timpl, Max Planck Institut fiir Biochemie, Martinsried, 
Federal Republic of Germany (13). Laminin was also tested after reaction with an equal weight 
of trypsin and Streptomyces griseus protease (Sigma Chemical Co., St. Louis, MO). Each of these 
antigens were tested at a concentration of 500 ng of antigen per well. 
Gel electrophoresis of the protein precipitated by serum from either control or infected 
monkeys, or of the affinity-purified antibodies, was carried out as described (8). Rabbits and 
sheep were immunized with laminin as previously described (8). The sera obtained from these 
animals, as well as sera from monkeys infected with T. cruzi, were chromatographed on a 
column of laminin-Sepharose (8). Unbound material was washed from the column with 0.02 M 
phosphate-buffered saline (PBS), pH 7.4, and the bound material containing the affinity- 
purified antibodies was eluted with 0.5 M NaCI, 0.5 M acetic acid, pH 3. The fractions 
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containing protein were adjusted to pH 7, dialyzed against PBS, and concentrated by 
uhrafihration. 
Immunoassays. Indirect IF (4) was used to test the reaction of antibodies obtained from 
humans and monkeys with freshly prepared cryostat sections of mouse peripheral nerve, skin, 
kidney, heart, and the EHS mouse tumor. The protease inhibitors p-hydroxymercuribenzoate 
(50 #g/ml) and phenylmethylsulfonyl fluoride (50 #g/ml) (Sigma Chemical Co.) were present 
during all steps of the reaction. In some experiments, the same section was exposed first to 
antibodies from infected monkeys purified by laminin-Sepharose affinity chromatography (50 
#g/ml) and then to antilaminin antibodies purified from rabbit serum (50 #g/ml). The tissue 
distribution of these antibodies was established with species-specific secondary fluorochromes 
(rhodamine conjugated goat anti-human IgG and fluorescein conjugated goat antirabbit IgG) 
(N. L. Cappel Laboratories, Inc., Cochranville, PA). 
Attempts were made to identify masked antigens by treating the tissue sections for 3 h with 
chondroitinase ABC (50 U/ml) (Miles Laboratories, Elkhart, IN) (14), testicular hyaluronidase 
(40 mg/ml) (Type IV, Sigma Chemical Co.), or purified bacterial collagenase form III (500 U/  
ml), Advance Biofactures, Lynbrook, NY) (15) before reaction with antibodies. 
The blocking reaction with collagen types I, III, IV, or V, fibronectin (FN), BM-1 proteo- 
glycan, chondronectin, laminin, or bovine serum albumin was performed at antigen concentra- 
tions of 150 btg/ml for 1 h at 37°C and overnight at 4°C. The antigens used were obtained 
from the following sources: type I collagen from lathyritic rat skin (16), type III collagen from 
a pepsin digest of fetal calf serum (17), type IV collagen from the EHS tumor (18), type V (cr- 
AB) from calf skin (19), FN from mouse serum (20), BM-1 proteoglycan from the EHS tumor 
(21), and chondroneein from chicken serum (22). When one of these materials inhibited 
fluorescence, a titer was obtained by absorbing the sera with different concentrations of antigen. 
The reactivity of sera from humans or Rhesus monkeys infected with T. cruzi with these 
components ofconnective tissue and laminin fragments (see above) were also tested by ELISA, 
using a concentration of 500 ng of antigen per well (23). 
The class of antibodies reacting with parasites tissue sections or laminin was assessed by 
immunofluorescence or by ELISA using fluorescein or peroxidase-conjugated goat antihuman 
IgG or IgM (N. L. Cappel Laboratories, Inc.). Radial immunodiffusion of antibodies with 
laminin was examined by Ouchterlony immunodiffusion at 4°C using 1% agarose by standard 
procedures. 
To demonstrate that laminin does not bind nonspecifically to other IgG molecules, we 
preincubated two sera containing antinuelear antibodies (ANA) with 150 ~g/ml of laminin for 
1 h at 37°C and overnight at 4°C, before performing the immunofluorescent reaction. Nuclei 
of hepatocytes were used as antigen. 
Attachment Assays. The attachment to a type IV collagen substrate of endothelial cells from 
sheep aorta, or of fibroblastic ells of the Chinese hamster ovary (CHO) line to plastic dishes, 
was measured in the presence and absence of sera or antibodies from infected primates as 
previously described (9). 
Resu l ts  
Distribution of the Antigen. In prel iminary studies, a careful analysis was made of 
the histological structures that were stained by the tissue-reacting antibodies in 
Chagas'  patients and infected monkey sera. In general, they reacted in those areas of 
tissue where basement membranes were present. The pattern resembled that obtained 
when antibodies to isolated basement membrane components, uch as laminin, were 
used (8). As discussed below, the tissue-reacting antibodies could be isolated by 
laminin Sepharose affinity chromatography.  
The reaction of antibodies from infected monkeys purif ied by laminin-Sepharose 
affinity chromatography (Fig. 1, first column) was compared with the reaction of 
rabbit  ant i laminin antibodies (Fig. 1, second column). Both antibodies howed an 
identical and intense staining of the extracel lular matr ix of the EHS tumor (not 
shown), and of per ipheral  nerve in the per ineurium, epineurium, and capillaries, and 
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Ftc. 1. Comparison by double immunofluorescence histochemistry of the tissue distribution f 
purified antibodies from monkeys infected with T. cruzi (first column) or from rabbits immunized 
with laminin (second column). Sections of m u e peripheral nerve (A and B), skin (C and D), kidney 
(E and F), and heart (G and H) are shown. 
a less intense staining of myelin sheaths (Fig. 1 A and B). Differences in IF were 
observed with other tissues. The antibodies from infected monkeys showed a broad 
distr ibution along the epidermal-dermal  junct ion of skin, including the epidermis 
(Fig. 1 C), whereas the ant i laminin antibodies from rabbits showed a l inear distribu- 
tion along the epidermal-dermal  junct ion (Fig. 1 D). In the kidney, the antibodies 
from infected monkeys strongly stained per i tubular  capillaries, glomerular endothe- 
l ium, and mesangiat matrix; but reacted only very weakly with the glomerular and 
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tubular basement membranes and did not stain Bowman's capsule (Fig. 1 E), whereas 
rabbit antilaminin antibodies trongly stained all kidney basement membranes (Fig. 
1 F). In the heart, the antibodies from infected monkeys localized in the endocardium, 
vessels, and interstitium in a diffuse distribution (Fig. 1 G) compared with the fine 
double line in certain regions with rabbit antilaminin antibodies (Fig. 1 H). 
Prior treatment of tissue sections with chondroitinase ABC, hyaluronidase, and 
bacterial collagenase did not change the distribution or the intensity of the staining 
with antibodies from infected primates. The whole sera from monkeys and humans 
infected with T. cruzi reacted with the same histological structures as the purified 
antibodies from infected monkeys. Laminin (25 #g/ml) completely blocked the 
reaction while other purified connective tissue components (i.e., collagen types I, III, 
IV, and V, FN, BM-1 proteoglycan, or chondronectin) had no effect. 
Immunochernical Characterization. ELISA assays indicated that sera from both acute 
and chronic patients contained antibodies to laminin and that the highest iters were 
present in the acute phase (Table I). No significant reaction of sera from patients 
infected with T. cruzi was observed with type I, III, IV, or V collagen, FN, BM-1 
proteoglycan, or chondronectin. Sera from the various other healthy and diseased 
humans or from uninfected monkeys did not react with tissues as judged by immu- 
nofluorescence and did not contain antibodies to laminin as judged by ELISA tests 
(titers ~:1:64). 
Monkeys and humans with acute T. crvzi infection had high titers (titers _>1:6000 
and ~ 1:1024, respectively) of IgM and IgG antibodies, which reacted with tissues and 
with laminin. The sera at the chronic stage of the infection had no reacting IgM 
(_<I :2) and lower titers of IgG (I :500). The shift from IgM and IgG antibodies present 
TAaLE I 
Immunofluorescence (IF) and ELISA Titers for Antibodies to Connective Tissue Components in Sera from 
Patients Infected with T~ypanosoma cruzi* 
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~1024 --~4096 --<64 --<32 -<64 -<32 -<32 -<32 _<32 
(1024-8192) (4096- 
~512 ~51.2 -<64 --<32 -<64 -<32 -<32 -<32 -<32 
(s12-204e) (512-2048) 
-<32 ! ----.32 N -<64 -<32 -<32 --<32 -<32 -<32 -<32 
-<64 -<64 -<32 -<64 -<32 -<32 -<32 -<32 -<32 
Statistically significant values are italicized. 
* Goat ant i -human IgG was used as a second antibody. 
:~ Indirect IF test using heart, skin, and EHS tumor cryostat sections as antigens. Each serum sample 
showed the same endpoint iter with all of the tissues tudied. 
i~The numbers in parenthesis represent the range of values. 
Two sera had antibody titers of 128. 
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at 3 mo of infection to only IgG antibodies at 12 mo after infection in monkeys was 
verified with the purif ied antibodies by immunoelectrophoresis and radial  immuno- 
diffusion. 
Laminin was precipitated from solution by sheep ant i laminin antibodies or by 
serum or antibodies purif ied from infected monkey serum. The presence of laminin in 
the precipitate was established by electrophoresis, based on the presence of two chains 
with Mr = 400,000 and 200,000 (Fig. 2). In addit ion, purif ied antibodies obtained 
from infected monkeys were found to precipitate laminin in a single line of identity 
with sheep ant i laminin antibodies (data not shown). 
When laminin was chromatographed on DEAE-cellulose under dissociating con- 
ditions (8 M urea), a single peak was eluted (Fig. 3). Electrophoresis of the fractions 
corresponding to this peak revealed the characteristic chains of laminin. The same 
peak contained material  that reacted in EL ISA tests with the serum from infected 
monkeys and sheep ant i laminin antibodies (Fig. 3), the purif ied antibodies from 
infected monkeys, or serum from infected humans (not shown). No reaction was 
Fro. 2. Gel electrophoresis of laminin immunoprecipitated with normal sheep serum (lane 1), 
normal monkey serum (lane 2), sheep antilaminin antiserum (lane 3), serum from a molakey infected 
with T. cruzi (lane 4), antibodies purified by laminin affinity chromatography of 4 (lane 5), and 
unbound fraction after laminin affinity chromatography of 4 (lane 6). Bands of Mr = 200,000 and 
400,000 correspond to laminin. 
Fro. 3. Identification of laminin after purification by DEAE cellulose chromatography. Each 
fraction was subjected to sodium dodecyl sulfate gel electrophoresis (A) and was assayed for laminin 
by ELISA (B). Std., laminin standard. 
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observed with normal monkey sera (Fig. 3) or with the fraction of infected monkey 
serum not bound to laminin-Sepharose. 
The specific antigenic site that reacted with antibodies from the infected monkeys 
and sheep antilaminin antibodies was further characterized by testing various pro- 
tease-derived fragments of laminin in the ELISA assay. The antigenic activity of both 
antibodies was retained in the PI and Pli fragments of laminin (Mr -- 280,000) 
produced by digestion with pepsin; however, when laminin was treated with Strepto- 
myces griseus protease or trypsin, its reactivity was lost (Table II). Laminin did not 
bind nonspecifically to other IgG molecules, because laminin did not block antinuclear 
antibodies from binding to the nuclei of hepatocytes. 
Reaction with Parasites. Antibodies (both the IgM and IgG types) from infected 
monkeys, purified by laminin-affinity chromatography, produced a very strong 
reaction with trypomastigotes and amastigotes, but showed only a weak reaction with 
epimastigotes when used in the indirect IF technique. Laminin (25 #g/ml) completely 
blocked this reaction. In contrast, the antibodies present in the infected serum, which 
did not bind to the laminin affinity column and which did not stain tissues, intensely 
stained the epimastigotes and amastigotes, but only weakly stained the trypomasti- 
gotes. 
Functional Studies. Laminin is the attachment protein that binds endothelial cells 
to type IV collagen (9). Serum from infected monkeys (Fig. 4), as well as serum from 
Chagas' patients, similarly inhibit the attachment of endothelial cells to type IV 
collagen, In addition, purified antibodies from infected monkeys (50 #g/ml) inhibit 
the attachment of these cells. This inhibition was reversed by the addition of laminin 
to the medium in which the cells were suspended (Fig. 4). As expected, the attachment 
of CHO fibroblasts, which is mediated by FN, was not inhibited by these antibodies 
(Fig. 5). 
Discussion 
Humans and monkeys infected with T. cruzi produce antibodies that react with 
extracellular structures in some areas where basement membranes are present. Their 
TABLE II 
Reaction of Laminin and Laminin Fragments with Antibodies Using the ELISA Technique 
Substrate 
Antibodies purified by 
affinity chromatography 
to laminin 






Laminin 1.2 I. 4 0.1 0.1 
Laminin plus trypsin 0.1 0. I 0. l 0.1 
Laminin plus S. griseus protease 0.1 0.1 0.1 0.1 
Laminin pepsin-derived fragments 
Pb 0.2 0.2 0.1 0.1 
Pc 0.1 0.2 0.1 0.1 
Pl 0.8 0.4 0.1 0.1 
Pli 0.8 0.8 0.1 0.1 
Detected with peroxidase-conjugated goatantihuman IgG. 
significant values are italicized. 
* At a concentration f50 #g/ml. 
~z Diluted 1:10. 
Absorbance was read at 492 nm. Statistically 
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FxG. 4. Inhibition by monkey serum of attachment ofendothelial cells to type IV collagen. The 
serum from an infected monkey inhibits the attachment to type IV collagen, and is reversed by 
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FIo. 5. Lack of inhibition by monkey serum of attachment ofCHO cells. Serum from an infected 
monkey and normal monkey serum has no effect. 
sera were found to contain high titers of antibodies to laminin but  not to various 
other connective tissue components. 
Several different tests were used to confirm the identif ication of laminin as the 
tissue antigen. These studies included immunoprec ip i tat ion f laminin,  absorption of 
the antibodies to laminin covalently bound to Sepharose beads, reaction of laminin 
with the antibodies in the Ouchter lony test, b inding of antibodies to laminin-coated 
wells (the EL ISA test), and inhibit ion of the attachment of endothel ial  and epithel ial  
ceils (not shown). For prel iminary studies using the EL ISA technique, we have found 
that laminin obtained from human amnion is able to block the reactivity of laminin 
antibodies obtained from infected pr imates to laminin obtained from the EHS tumor 
(A. Szarfman, V. P. Terranova, and G. R. Mart in,  unpubl ished observation). The P1 
and Pli fragments of laminin produced by proteolytic digestion shows a high degree 
of reaction with these antibodies. Furthermore,  it is likely that laminin represents the 
major, or even the only, tissue antigen in the EVI system, because passage of sera 
from Chagas'  patients or infected monkeys over laminin-Sepharose b ads el iminates 
the tissue reactions. 
Direct comparison of the reaction of these antibodies with rabbit  antibodies to 
laminin in tissue sections revealed similar, but not identical, reactions. The antigen in 
tissues reacting with antibodies from infected monkey serum is more labile than the 
antigen detected by ant i laminin antibodies produced in rabbits (data not shown). 
Furthermore, rabbit  ant i laminin antibodies tained all basement membranes uni- 
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formly, whereas the antibodies from infected primates howed a more limited distri- 
bution. However, both sera stained the matrix of the EHS tumor, which is thought o 
be solely basement membrane (18). It is likely that these two antibodies recognize 
different antigenic sites in laminin. The sheep or rabbit antibodies are probably 
heterogeneous and directed against a variety of antigenic sites in the laminin molecule. 
The antibodies arising after T. cruzi infection may recognize fewer and different 
antigenic determinants in laminin. The interaction of laminin with other components 
of the basement membrane, such as type IV collagen and the heparan sulfate 
proteoglycan, might mask some antigenic sites and make the protein unreactive with 
antibodies which recognize a limited number of antigenic determinants. Therefore, 
laminin may be a heterogeneous family of proteins or could exist in several stages of 
processing which could affect the reactivity and specificity of the antigen. 
After infection by T. cruzi, antibodies are produced against laminin and not against 
any of the other known basement membrane or connective tissue components. 
Furthermore, production of antibodies against laminin is a distinctive feature of T. 
cruzi infection in primates. Such antibodies are not present in sera from normal 
individuals, persons who have undergone surgery, or patients with various inflam- 
matory conditions or neoplasms, malaria, toxoplasmosis, or rheumatoid arthritis. 
However, we have found high titers of antibodies to laminin in Rhesus monkeys 
infected with T~ypanosoma rhodesiense (A. Szarfman, K. Esser, V. P. Terranova, and G. 
R. Martin, unpublished observation). It is possible that the induction of antibodies to 
laminin is associated with trypanosomal infections. 
It is not clear why T. cruzi infection induces antibodies to laminin. The titer of 
antibodies is highest during the early phase of the infection as would be expected if
laminin or an immunologically related protein were produced by the parasite. In this 
regard, we have found that the trypomastigote and amastigote forms of the parasite 
have a higher reactivity with purified antibodies from infected monkeys than the 
epimastigote forms. Furthermore, recent studies have shown that sera from Chagas' 
patients increase the attachment and penetration of blood trypomastigotes into WI 
38 cells (24), and that purified antibodies to laminin decrease the penetration of the 
parasites (Dr. G. A. Schmufiis, personal communication). Because the trypomastigote 
form of T. cruzi encounters basement membranes during its penetration i to the host, 
the production of a laminin-like protein and or incorporation of host laminin may 
permit the parasite to interact with the host tissues. 
The significance of the antilaminin antibodies to the pathol6gy of Chagas' disease 
is unclear. As shown here, the antibodies in infected monkeys that react with laminin 
are able to block the attachment of endothelial cells to basement membranes, and 
this could damage blood vessels and endocardium leading to the endocardial fibrosis 
found in Chagas' disease (1) and in African Trypanosomiasis (25). The initial changes 
would arise during the parasitic invasion of the host, and the changes that occur later 
on would be part of a slow destructive process econdary to autoimmune reactions 
(26, 27). The study of the antilaminin antibodies that appear after infection with T. 
cruzi holds considerable promise of yielding important information of the interactions 
of the parasite and it's host. In addition, when immunization with T. cruzi is taken 
into consideration, these antibodies can become useful in producing antigenic prep- 
arations of T. cruzi, void of host tissue components. 
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Summary  
We have found that sera from humans with Chagas'  disease and Rhesus monkeys 
infected with Trypanosoma cruzi contain IgM and IgG antibodies, which react with 
structures in a variety of connective tissues. These antibodies react with laminin but 
not with various other purif ied connective tissue components like collagen types I, I I I, 
IV, and V, fibronectin, heparan sulfate (BM-1) proteoglycan, or chondronectin. The 
tissue-reacting antibodies were isolated by absorption to a laminin-Sepharose column. 
The bound fraction contained all the tissue-reacting antibodies. These antibodies 
strongly stained trypomastigotes and amastigotes, but weakly stained epimastigotes. 
These studies show that sera from T. cruzi-infected primates contain ant i laminin 
antibodies, which may be produced by those host in response to a laminin-l ike 
molecule present in the parasite. 
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